XRCC1 and lung carcinoma: We observed that the Arg194Trp and Arg399Gln genetic polymorphisms in XRCC1 gene were not statistically influenced the median PFS in all advanced lung cancer patients with platinum-based chemotherapy treatment (Figs. 2C and 3C, Tables 3 and 4).